THIẾT LẬP QUY TRÌNH TỔNG HỢP IN VITRO PHÂN ĐOẠN RNA CỦA 5 LOÀI VIRUS EBOLA

Đinh Thị Thu Hằng1, Bùi Tiến Sỹ2, Hồ Hữu Thọ1, Nguyễn Thái Sơn3, Hoàng Xuân Sử1
1 Trung tâm Nghiên cứu Y Dược học Quân sự, Học viện Quân y
2 Bệnh viện Trung ương Quân đội 108
3 Bệnh viện Quân y 103, Học viện Quân y

Nội dung chính của bài viết

Tóm tắt

DEVELOPMENT OF A NOVEL ASSAY FOR IN VITRO SYNTHESIS OF THE RNA FRAGMENTS SPECIFYING 5 EBOLA VIRUS SPECIES

An in vitro transcribed RNA protocol of 5 pathogenic Ebola virus species ZEBOV, SEBOV, BEBOV, TEBOV, REBOV using synthesized plasmids was established with high efficient and following steps: (1) Cloning synthesized plasmids containing NP sequence and 3'UTR region of EBOV in E. coli; (2) 20 μl volume in vitro RNA transcription reaction: 5X TranscriptAid Reaction Buffer; 10 mM dNTPs mix; 0.8 - 1 μg plasmid DNA; 2 μl TranscriptAid Enzyme Mix and DEPC-treated water, 37 °C /2 hours, 2 μl DNase I, 37 °C /15 minutes by TranscriptAid T7 High Yield Transcription Kit. (3) Evaluation of in vitro transcribed RNA by electrophoresis and one-step RT-PCR assay. The in vitro transcribed RNA of 5 Ebola virus species with 900-1400 ng/µl concentration and from 1.8-2.1 A260/A280 ratio.

Chi tiết bài viết

Tài liệu tham khảo

1. Nguyễn Văn An, Nguyễn Thái Sơn, Bùi Tiến Sỹ, Hoàng Xuân Sử, Hồ Hữu Thọ, Đinh Thị Thu Hằng, Phát triển kỹ thuật reverse transcription polymerase chain reaction xác định virut Ebola, Tạp chí Y Dược học Quân sự, 2016, 41(8):74-79.
2. Broadhurst M.J., Brooks T.J., Pollock N.R., Diagnosis of Ebola Virus Disease: Past, Present, and Future, Clin Microbiol Rev, 2016, 29(4):93-773.
3. Burd E.M., Validation of laboratory-developed molecular assays for infectious diseases, Clin Microbiol Rev, 2010, 23(3):76-550.
4. Formenty P., Leroy E.M., Epelboin A., Libama F., Lenzi M., Sudeck H., Yaba P., Allarangar Y., Boumandouki P., Nkounkou V.B., Drosten C., Grolla A., Feldmann H., Roth C., Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo, Clin Infect Dis, 2006, 42(11):1521-1526.
5. Gibb T.R., Norwood D.A., Woollen N., Henchal E.A., Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan, J Clin Microbiol, 2001, 39(11):30-4125.
6. Huang Y., Wei H., Wang Y., Shi Z., Raoul H., Yuan Z., Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays, Virol Sin, 2012, 27(5):7-273.
7. Licata J.M., Johnson R.F., Han Z., Harty R.N., Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles, J Virol, 2004, 78(14):7344-51.
8. Pang Z., Li A., Li J., Qu J., He C., Zhang S., Li C., Zhang Q., Liang M., Li D., Comprehensive multiplex one-step real-time TaqMan qRT-PCR assays for detection and quantification of hemorrhagic fever viruses, PLoS One, 2014, 9(4): e95635.
9. Sanchez A., Ksiazek T.G., Rollin P.E., Miranda M.E., Trappier S.G., Khan A.S., Peters C.J., Nichol S.T., Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates, J Infect Dis, 1999, 179(1):S164-9.
10. Towner J.S., Rollin P.E., Bausch D.G., Sanchez A., Crary S.M., Vincent M., Lee W.F., Spiropoulou C.F., Ksiazek T.G., Lukwiya M., Kaducu F., Downing R., Nichol S.T., Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome, J Virol, 2004, 78(8):41-4330.